ELI LILLY & Co (LLY)
Health Care / Pharmaceuticals
$988.58
Middle of the pack. No strong signal either way.
Hold
Score based on 5 of 5 models — high confidence
Key Metrics
Estimated Fair Value
Trading above estimated fair value. P/e of 43x implies high growth expectations. rapid eps growth (96%) partially justifies the premium.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Strong
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Neutral
High PEG — growth premium · Stalwart
Greenblatt
Caution
Top half (rank 31%)
Similar Stocks
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer